Alzheimer’s Disease News and Research RSS Feed - Alzheimer’s Disease News and Research

Newly identified compound may halt progression of Alzheimer's disease

Newly identified compound may halt progression of Alzheimer's disease

Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of Alzheimer's patients, contributing to the condition's hallmark memory loss, confusion and cognitive decline. [More]
Sleep may enhance memory formation

Sleep may enhance memory formation

Sleep could play a major role in our ability to form long-term memories, suggest study findings. [More]
National Institutes of Health awards $3.4M grant for Alzheimer's disease research

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

As part of its ongoing research to better understand the complexities of the human brain, the Allen Institute for Brain Science is embarking on the first effort to map connectivity patterns across the whole brain in mouse models of Alzheimer's disease, through its recent award of a $3.4 million grant over five years from the National Institute on Aging of the National Institutes of Health. [More]
Tailored light treatment can improve sleep and behavior in people with Alzheimer's disease

Tailored light treatment can improve sleep and behavior in people with Alzheimer's disease

A new study suggests that light treatment tailored to increase circadian stimulation during the day may improve sleep, depression and agitation in people with Alzheimer's disease and related dementia. [More]
NYU Langone scientists identify promising treatment target for Alzheimer's disease

NYU Langone scientists identify promising treatment target for Alzheimer's disease

Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer's disease. [More]
Study warns against use of resveratrol supplements by pregnant women

Study warns against use of resveratrol supplements by pregnant women

A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology. [More]
Critically ill patients receiving steroids in ICU are more likely to develop delirium

Critically ill patients receiving steroids in ICU are more likely to develop delirium

New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital’s intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU. [More]
Research findings could lead to new approach to Alzheimer’s prevention

Research findings could lead to new approach to Alzheimer’s prevention

In surprise findings, scientists at The Scripps Research Institute have discovered that a protein with a propensity to form harmful aggregates in the body when produced in the liver protects against Alzheimer’s disease aggregates when it is produced in the brain. The results suggest that drugs that can boost the protein’s production specifically in neurons could one day help ward off Alzheimer’s disease. [More]
Drugs that boost protein's production in neurons could help ward off Alzheimer's disease

Drugs that boost protein's production in neurons could help ward off Alzheimer's disease

In surprise findings, scientists at The Scripps Research Institute (TSRI) have discovered that a protein with a propensity to form harmful aggregates in the body when produced in the liver protects against Alzheimer's disease aggregates when it is produced in the brain. [More]
Researchers identify heart-specific form of protein that protects against irregular heartbeats

Researchers identify heart-specific form of protein that protects against irregular heartbeats

Researchers at the Cedars-Sinai Heart Institute have identified a heart-specific form of a protein, BIN1, responsible for sculpting tiny folds in pockets that are present on the surface of heart muscle cells. [More]
Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

In 2008, researchers at the Perelman School of Medicine at the University of Pennsylvania showed that mutations in two proteins associated with familial Alzheimer's disease (FAD) disrupt the flow of calcium ions within neurons. [More]
Anti-depressants could slow onset of Alzheimer's disease

Anti-depressants could slow onset of Alzheimer's disease

A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer's disease (AD). [More]
Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

A commonly prescribed antidepressant can reduce production of the main ingredient in Alzheimer's brain plaques, according to new research at Washington University School of Medicine in St. Louis and the University of Pennsylvania. [More]
Scientists discover novel protein fragments that may protect against Alzheimer's disease

Scientists discover novel protein fragments that may protect against Alzheimer's disease

The devastating loss of memory and consciousness in Alzheimer's disease is caused by plaque accumulations and tangles in neurons, which kill brain cells. [More]

Characterization of Cajal-Retzius cells during development in mouse model of Alzheimer's disease

Cajal-Retzius cells are reelin-secreting neurons in the marginal zone of the neocortex and hippocampus. [More]
Mayo Clinic neuroscientists define subtype of Alzheimer's disease

Mayo Clinic neuroscientists define subtype of Alzheimer's disease

Neuroscientists at Mayo Clinic in Florida have defined a subtype of Alzheimer's disease (AD) that they say is neither well recognized nor treated appropriately. [More]
Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease

Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease

​A study of older adults at increased risk for Alzheimer's disease shows that moderate physical activity may protect brain health and stave off shrinkage of the hippocampus- the brain region responsible for memory and spatial orientation that is attacked first in Alzheimer's disease. [More]

Scientists find new insight into interaction between proteins associated with Alzheimer's disease

Getting to the bottom of Alzheimer's disease has been a rapidly evolving pursuit with many twists, turns and controversies. In the latest crook in the research road, scientists have found a new insight into the interaction between proteins associated with the disease. The report, which appears in the journal ACS Chemical Neuroscience, could have important implications for developing novel treatments. [More]
Rhenovia Pharma's SMARTT e-Patch project wins award at the French ‘World Innovation Challenge'

Rhenovia Pharma's SMARTT e-Patch project wins award at the French ‘World Innovation Challenge'

Rhenovia Pharma, a biotechnology company specialized in the application of biosimulation to the research and development of new medicinal products, today announces that its SMARTT e-Patch project has won an award at the ‘World Innovation Challenge’; founded by the President of France to identify future champions in the French economy. [More]
Researchers uncover novel function of Amyloid Precursor Protein linked to Alzheimer's disease

Researchers uncover novel function of Amyloid Precursor Protein linked to Alzheimer's disease

A research team led by the National Neuroscience Institute has uncovered a novel function of the Amyloid Precursor Protein (APP), one of the main pathogenic culprits of Alzheimer's disease. This discovery may help researchers understand how the protein goes awry in the brains of Alzheimer's disease patients, and potentially paves the way for the development of innovative therapeutics to improve the brain function of dementia patients. [More]